Subsidiary AP Biosciences and Tasly Biopharmaceuticals Signed Cooperative Development and Authorized Agreement of New Antibody Drug

Date of occurrence of the event: Jul 29, 2019 Counterparty to the contract or commitment: Tasly Biopharmaceuticals Co. Ltd Relationship to the Company: None Starting and ending dates (or rescission date) of the contract or commitment: Jul 26, 2019 Major content (not applicable where rescinded): Subsidiary of 67 % stock owned OBI Pharma Inc. (abbrev. […]